OTLC
Oncotelic Therapeutics, Inc.
-0.00 (-14.33%)0.03USD55.1K成交股數11.8M市值0.0本益比(近四季)47.0股價營收比–營收年增(近四季)–下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 250K | – | – | – | – | – | – | – | – | – | 70K | – |
| 營業成本 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 毛利率 | – | – | – | – | – | – | – | – | – | – | – | – |
| 研發費用 | 345.00 | 795.00 | – | – | 297.00 | 297.00 | 480.00 | 252.00 | 480.00 | – | 21K | – |
| 銷售管理費用 | 1.1M | 1.9M | 2.5M | 491K | 66K | 101K | 80K | 96K | 167K | 102K | 34K | 239K |
| 營業利益 | −844K+1179% | −1.9M+1733% | −2.5M-23% | −491K+408% | −66K-61% | −101K+32% | −3.3M-22760% | −97K-98% | −167K | −76K | 14K | −6.3M |
| 營業利益率 | -337.4% | – | – | – | – | – | – | – | – | – | 20.7% | – |
| 稅後淨利 | 388K+40% | −2.2M+634% | 250M-7677% | −1.0M+399% | 278K-168% | −299K-59% | −3.3M-2966% | −210K-97% | −409K | −736K | 115K | −6.8M |
| 淨利率 | 155.3% | – | – | – | – | – | – | – | – | – | 164.7% | – |
| 稀釋 EPS | 0.00 | 0.00 | – | – | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | – | 0.00 | – |
| 稀釋股數 | 468M | 444M | 422M | – | 453M | 407M | 407M | 402M | 399M | 396M | 398M | – |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | – | – | – | 409K | 88K | 79K | 149K | 72K | 189K | 170K | – | – |
| 應收帳款 | 2K | 2K | 51K | 4K | 19K | 19K | 19K | 19K | 19K | 19K | 19K | 19K |
| 存貨 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總資產 | 395M | 394M | 393M | 28.2M | 26.7M | 26.7M | 26.8M | 29.9M | 30.0M | 30.0M | 30.1M | 30.0M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 131M | 132M | 131M | 20.1M | 19.3M | 19.5M | 18.7M | 18.4M | 18.7M | 18.4M | – | – |
| 股東權益 | 265M | 263M | 263M | 9.1M | 8.3M | 8.0M | 8.9M | 12.2M | 11.8M | 12.1M | 12.5M | 12.3M |
| 負債比 | 33.3% | 33.4% | 33.4% | 71.3% | 72.3% | 73.1% | 69.6% | 61.6% | 62.5% | 61.3% | – | – |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 | 23Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −342K+105% | – | – | – | −167K | – | – | −231K | – | – | – |
| 資本支出 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流 | – | – | – | – | – | – | – | – | – | – | – | – |
| 折舊攤銷 | – | – | – | – | – | – | – | – | – | – | – | – |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | – | – | – | – | – | – | – | – | – | – | – |
營收拆解 2023 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2023 年度 · 70K
| 服務 | 70K | 100.0% | – |
|---|
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | – | – | 249M | –% | 0.59 | – |
| FY2024 | – | – | −4.5M | –% | -0.01 | – |
| FY2023 | 70K | – | −7.9M | -11,290.1% | -0.02 | – |
| FY2022 | – | – | 5.1M | –% | 0.01 | – |
| FY2021 | – | – | −9.4M | –% | -0.03 | – |
| FY2020 | 1.7M | – | −9.5M | -545.9% | -0.11 | – |
| FY2019 | – | – | −6.6M | –% | -0.11 | – |
| FY2018 | – | – | −713K | –% | -0.12 | – |